NIDA is now accepting applications for the 2025 NIDA Diversity Scholars Network (NDSN). Apply now! The application period will close on January 31, 2025 at 11:59pm PT.
The NDSN program is a comprehensive program aimed at enhancing the funding success of early-stage investigators from diverse backgrounds, including investigators from underrepresented groups. See: Notice of NIH's Interest in Diversity NOT-OD-20-031. The program provides workshops and supportive coaching as participants prepare a complete research or career development award application for NIDA funding consideration. The program culminates in a mock review of the participants’ applications.
NDSN Program Framework
The NDSN program consists of three separate meetings. The Part I meeting focuses on demystifying the NIH grants process, grant writing fundamentals, and engagement with NIDA Program Officials/Coaches. Scholars will be paired with a NIDA Program Official (PO) to discuss their proposal’s general fit with NIDA’s research priorities and the appropriateness of your proposed grant mechanism and/or notice of funding opportunity (NOFO). They are also matched with an experienced addiction scientist (Coach) to discuss their research proposal which will be used as the basis for their NDSN mock review grant application. Scholars have the option to maintain periodic contact with their POs and Coaches following the program to further develop and seek feedback on their draft NIH application.
The Part II meeting includes expert advice on starting a research career, understanding peer review, and an overview of the anatomy of a grant application. Scholars will also hear from past NDSN scholars and can network with other program participants. The two-day Part III meeting consists of a mock review meeting, discussion with NIDA reviewers on common grant writing pitfalls and strategies and building resilience. Alll scholars are required to participate in all three meetings. The NDSN program's Part I and Part II are conducted virtually, and the Part III 2-day meeting is in-person. NIDA will provide scholars with round-trip airfare, lodging, per diem, and ground transportation to travel to Bethesda, MD for the Part III meeting.
Testimonials
Being an NDSN scholar was one of the best experiences I have had as a scientist! The application to the Program itself challenged me to formulate a coherent research proposal, and the timeline built into the Program provided structure for me to flesh out the idea and compose other elements in the application. The mock review from experts in substance use and addiction—and other relevant content areas—was by far the most eye-opening experience. I also learned about the Early Career Reviewer Program in NIH, and reached out to Scientific Review Officers to become involved in peer reviews. Reviewing others’ applications helped me understand better NIH review criteria and process. Based on my product from the NDSN Program, I recently received funding from NIDA on my first (R01) grant. Having had limited opportunities to assist with mentors’ grant applications and not being eligible for most NIH’s predoctoral mechanisms, I think the NDSN Program offered such opportunities and helped bridge some gaps in my repertoire as a scientist.
– Priscilla Lui, PhD
Professor Department of Psychology at the University of Washington
2024 NDSN Program Participant Feedback
“Loved the program thank you for organizing and pulling back the curtain on a hidden curriculum” – 2024 NDSN scholar
“My experience participating in the NDSN program certainly met my expectations. I am much more familiar with the whole grant submission and review process than I was before. I am confident that I can address the comments I have received along the way to improve my proposal.” – 2024 NDSN scholar
“I have nothing but positive feedback. The individual/tailored feedback provided by my coach and PO were invaluable to shaping my grant revisions, and the public mock review was immensely helpful. It was also wonderful being able to meet and receive support from colleagues at my own career level as well as leaders in the field.” – 2024 NDSN scholar
Eligibility Requirements
- Ph.D., M.D., Pharm. D., Psy.D., R.N./Ph.D., or equivalent doctoral degree
- Minimum of two full years of research experience after the terminal degree (at the time of application)
- Must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status
- Must be within 10 years of receipt of their terminal degree*
- No prior successful NIH research or career development awards (fellowships awardees are eligible)
- Minimum of two published first-authored peer reviewed papers within the last three years
- Positioned to submit an NIH Research Grant or Mentored Career Development Award application within a year of program participation
- Previous NDSN participants are not eligible to apply
- Attendance at all program meetings
*Please contact us at NDSN@nih.gov regarding limited exceptions
Application Process
The NDSN application for the 2025 NDSN program will close at 11:59pm PT on January 31, 2025. The following components are required:
- A candidate statement (2 pages maximum)
- Specific aims (1 page maximum)
- Abbreviated research strategy (6 pages maximum, excluding references)
- Notice of Funding Opportunity (NOFO) number and/or grant mechanism of interest along with the NIDA Program Official you are currently working with (if you have been in contact with someone already)
- The applicant’s CV (no page limit), must include publications
- Applicant’s ORCHID ID and/or MyNCBI link
Candidate Statement Requirements
The Candidate Statement (maximum of 2 pages) must include:
- Citizenship status
- Your background
- Your expertise and training (formal and informal)
- Your career plans
- Why you are applying to be an NDSN scholar (i.e., what do you hope to gain from participation?)
- How your research relates to NIDA’s Strategic Plan
Consider integrating the following into your candidate statement, as relevant:
- Previous research and scholarship achievements
- Your specific contributions to science
- Your Diversity Equity Inclusion Accessibility (DEIA) related activities and leadership
- Factors that affected your past productivity
- How your research goals and background align with NIH’s Interest in Diversity
Selection Criteria:
- Strength of the candidate statement
- Candidate well positioned to submit competitive research application
- Priority of research project for NIDA
An internal committee will select up to 12 scholars to participate in the program. Selected scholars will be notified by email by late February, 2025. For any questions about the NDSN Program application process, please contact us at NDSN@nih.gov or see the NDSN FAQs page.
2025 Program Timeline:
- November 2024 – Application opens
- January 2025 – Application due
- February 2025 – Selected participants notified
- March 2025 – Part 1 Meeting
- June 2025 – Part II Meeting
- July 2025 – Mock review final grant application submitted to NIDA
- September 2025 – Part III Meeting
NIDA Diversity Scholars Network Pre-Application Webinar
Held on 11/4/2025
Topics discussed:
- Eligibility and the application process
- Learn about what each part of the program entails
- Hear about the various NIH funding mechanisms, and determine which is the best fit for you
- Learn how to connect with NIDA Program Officers to discuss your research direction
- Hear from the NIDA Deputy Director and Director of the ORTDD, Dr. Wilson Compton
NSDN Pre-Application Webinar (PDF 1.7MB)
Frequently Asked Questions
NIDA Diversity Workshop: Dr. Dionna Williams
NIDA Diversity Scholars Network Program 2024 Cohort
NIDA Diversity Scholars Network Program 2023 Cohort
NIDA Diversity Scholars Network Program 2022 Cohort
NIDA Diversity Scholars Network Program 2021 Cohort
Publications
Avila AH, Weixelbaum JH, Goggans KR, Compton WM. The national institute on drug abuse diversity scholars network: success for a diverse addiction science workforce. Neuropsychopharmacology. 2023 Sep 19. doi: 10.1038/s41386-023-01733-x. Epub ahead of print. PMID: 37726356.